These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


5645 related items for PubMed ID: 2635671

  • 21. Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
    Atassi G, Dumont P, Gosse C, Fournier JP, Gouyette A, Roger P.
    Cancer Chemother Pharmacol; 1989; 25(3):205-9. PubMed ID: 2598412
    [Abstract] [Full Text] [Related]

  • 22. [Study on inhibitory effect of ampelopsin on melanoma by serologic pharmacological method].
    Liu D, Luo M.
    Zhong Yao Cai; 2001 May; 24(5):348-50. PubMed ID: 12587211
    [Abstract] [Full Text] [Related]

  • 23. [Preliminary study on molecular mechanism of curcumine anti-mouse melanoma].
    Gui F, Ma WF, Cai SH, Li XK, Tan Y, Zhou CL, Chen HY.
    Zhong Yao Cai; 2008 Nov; 31(11):1685-9. PubMed ID: 19260281
    [Abstract] [Full Text] [Related]

  • 24. [Changes in biological properties of malignant melanoma B-16 after transplantation to (CBA x C57Bl/6)F1 mice].
    Kiseleva EG, Volkova LM, Iakushchenko TN, Konovalova NP.
    Eksp Onkol; 1988 Nov; 10(5):49-52. PubMed ID: 3208690
    [Abstract] [Full Text] [Related]

  • 25. Antineoplastic activity of azacarbazoles. II. Effect of alpha-carboline and its derivatives on transplantable animal neoplasms.
    Fiszer-Maliszewska L, Mordarski M.
    Arch Immunol Ther Exp (Warsz); 1987 Nov; 35(2):221-4. PubMed ID: 3447536
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis.
    Shah JH, Swartz GM, Papathanassiu AE, Treston AM, Fogler WE, Madsen JW, Green SJ.
    J Med Chem; 1999 Aug 12; 42(16):3014-7. PubMed ID: 10447943
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
    Aboagye EO, Dillehay LE, Bhujwalla ZM, Lee DJ.
    Radiat Oncol Investig; 1998 Aug 12; 6(6):249-54. PubMed ID: 9885940
    [Abstract] [Full Text] [Related]

  • 29. Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents.
    Griswold DP.
    Cancer Chemother Rep 2; 1972 Nov 12; 3(1):315-24. PubMed ID: 4660734
    [No Abstract] [Full Text] [Related]

  • 30. [Induced resistance of experimental tumors to nitrosomethylurea].
    Krutova TV, Ostrovskaia LA.
    Vopr Onkol; 1982 Nov 12; 28(11):48-52. PubMed ID: 7147832
    [Abstract] [Full Text] [Related]

  • 31. [The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma].
    Zhang H, Feng Z, Zhang G.
    Zhonghua Zhong Liu Za Zhi; 1999 Nov 12; 21(6):416-8. PubMed ID: 11776614
    [Abstract] [Full Text] [Related]

  • 32. [Dependence of the antitumor activity of nitroso alkyl urea derivatives on their chemical structure].
    Sharashidze LK, Turkiia NG, Lagidze DR, Adamiia IK, Asatiani VV.
    Eksp Onkol; 1989 Nov 12; 11(2):62-5. PubMed ID: 2737133
    [Abstract] [Full Text] [Related]

  • 33. Histological localization of 4-S-cysteinylphenol in melanoma-bearing mice.
    Nakamura T, Matsubara O, Kasuga T, Suzuki J, Ishikawa K, Ito S.
    Bull Tokyo Med Dent Univ; 1987 Dec 12; 34(4):93-8. PubMed ID: 3327627
    [Abstract] [Full Text] [Related]

  • 34. [The genetic correction of the mutagenic properties of fotrin by using the interferon inducer larifan in spontaneously metastasizing Lewis lung carcinoma].
    Zolotareva GN, Loginova NS, Luchinova IM, Kinzirskiĭ AS.
    Vopr Onkol; 1993 Dec 12; 39(4-6):196-202. PubMed ID: 7975396
    [No Abstract] [Full Text] [Related]

  • 35. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
    Shyam K, Penketh PG, Loomis RH, Rose WC, Sartorelli AC.
    J Med Chem; 1996 Feb 02; 39(3):796-801. PubMed ID: 8576923
    [Abstract] [Full Text] [Related]

  • 36. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F, Decaestecker C, Gaussin JF, Mortier S, Van Ginckel R, Kiss R.
    Int J Oncol; 2005 Sep 02; 27(3):607-16. PubMed ID: 16077908
    [Abstract] [Full Text] [Related]

  • 37. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B, Shen RN, Wang WX, Broxmeyer HE, Lu L.
    Stem Cells; 1993 Sep 02; 11(5):412-21. PubMed ID: 8241952
    [Abstract] [Full Text] [Related]

  • 38. Antitumor effect of avermectins.
    Drinyaev VA, Mosin VA, Kruglyak EB, Novik TS, Sterlina TS, Ermakova NV, Kublik LN, Levitman MKh, Shaposhnikova VV, Korystov YN.
    Eur J Pharmacol; 2004 Oct 06; 501(1-3):19-23. PubMed ID: 15464058
    [Abstract] [Full Text] [Related]

  • 39. Antitumor activity of bestatin and thiorphan in mice.
    Kowalski J, Belowski D, Madej A, Herman ZS.
    Arch Immunol Ther Exp (Warsz); 1995 Oct 06; 43(5-6):265-71. PubMed ID: 8744646
    [Abstract] [Full Text] [Related]

  • 40. Antiproliferative activity of berberine in vitro and in vivo.
    Letasiová S, Jantová S, Múcková M, Theiszová M.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec 06; 149(2):461-3. PubMed ID: 16601810
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 283.